Foghorn Therapeutics Inc. Depreciation and Amortization
Foghorn Therapeutics Inc. (FHTX) reported Depreciation and Amortization of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-06
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $200.00K, a 77.78% decline year-over-year.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $238.00K, a 71.22% decline year-over-year.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $802.00K, a 5.39% increase year-over-year.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $900.00K, a 28.57% increase year-over-year.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for fiscal 2025 was $3.33M, a 6.79% increase from fiscal 2024.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for fiscal 2024 was $3.12M, a 9.59% decline from fiscal 2023.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for fiscal 2023 was $3.45M, a 3.91% increase from fiscal 2022.
- Foghorn Therapeutics Inc. depreciation, depletion and amortization for fiscal 2022 was $3.32M, a 2.91% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-06 | $468.00K 10-Q · filed 2026-08-06 | $1.24M derived: sum of 3 quarters · filed 2026-08-06 | $2.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $238.00K 10-Q · filed 2026-05-07 | $1.04M derived: sum of 2 quarters · filed 2026-05-07 | $1.94M derived: sum of 3 quarters · filed 2026-05-07 | $2.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $802.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.70M derived: sum of 2 quarters · filed 2026-03-11 | $2.60M derived: sum of 3 quarters · filed 2026-08-06 | $3.33M 10-K · filed 2026-03-11 |
| 2025-09-30 | $900.00K 10-Q · filed 2025-11-05 | $1.80M derived: sum of 2 quarters · filed 2026-08-06 | $2.53M 10-Q · filed 2025-11-05 | $3.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $900.00K 10-Q · filed 2026-08-06 | $1.68M 10-Q · filed 2026-08-06 | $2.49M derived: sum of 3 quarters · filed 2026-08-06 | $3.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $827.00K 10-Q · filed 2026-05-07 | $1.59M derived: sum of 2 quarters · filed 2026-05-07 | $2.29M derived: sum of 3 quarters · filed 2026-05-07 | $3.09M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $761.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.46M derived: sum of 2 quarters · filed 2026-03-11 | $2.26M derived: sum of 3 quarters · filed 2026-03-11 | $3.12M 10-K · filed 2026-03-11 |
| 2024-09-30 | $700.00K 10-Q · filed 2025-11-05 | $1.50M derived: sum of 2 quarters · filed 2025-11-05 | $2.36M 10-Q · filed 2025-11-05 | $3.19M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $800.00K 10-Q · filed 2025-08-05 | $1.63M 10-Q · filed 2025-08-05 | $2.49M derived: sum of 3 quarters · filed 2025-08-05 | $3.39M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $835.00K 10-Q · filed 2025-05-14 | $1.69M derived: sum of 2 quarters · filed 2025-05-14 | $2.59M derived: sum of 3 quarters · filed 2025-05-14 | $3.39M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.75M derived: sum of 2 quarters · filed 2025-03-06 | $2.55M derived: sum of 3 quarters · filed 2025-03-06 | $3.45M 10-K · filed 2025-03-06 |
| 2023-09-30 | $900.00K 10-Q · filed 2024-11-04 | $1.70M derived: sum of 2 quarters · filed 2024-11-04 | $2.60M 10-Q · filed 2024-11-04 | $3.41M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $800.00K 10-Q · filed 2024-08-08 | $1.74M 10-Q · filed 2024-08-08 | $2.51M derived: sum of 3 quarters · filed 2024-08-08 | $3.41M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $859.00K 10-Q · filed 2024-05-06 | $1.71M derived: sum of 2 quarters · filed 2024-05-06 | $2.61M derived: sum of 3 quarters · filed 2024-05-06 | $3.41M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $848.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.75M derived: sum of 2 quarters · filed 2024-03-07 | $2.55M derived: sum of 3 quarters · filed 2024-03-07 | $3.32M 10-K · filed 2024-03-07 |
| 2022-09-30 | $900.00K 10-Q · filed 2023-11-02 | $1.70M derived: sum of 2 quarters · filed 2023-11-02 | $2.47M 10-Q · filed 2023-11-02 | $3.32M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $800.00K 10-Q · filed 2023-08-04 | $1.63M 10-Q · filed 2023-08-04 | $2.42M derived: sum of 3 quarters · filed 2023-08-04 | $3.22M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $811.00K 10-Q · filed 2023-05-08 | $1.62M derived: sum of 2 quarters · filed 2023-05-08 | $2.42M derived: sum of 3 quarters · filed 2023-05-08 | $3.22M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $810.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.61M derived: sum of 2 quarters · filed 2023-03-09 | $2.41M derived: sum of 3 quarters · filed 2023-03-09 | $3.23M 10-K · filed 2023-03-09 |
| 2021-09-30 | $800.00K 10-Q · filed 2022-11-08 | $1.60M derived: sum of 2 quarters · filed 2022-11-08 | $2.42M 10-Q · filed 2022-11-08 | $2.94M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $800.00K 10-Q · filed 2022-08-09 | $1.56M 10-Q · filed 2022-08-09 | $2.13M derived: sum of 3 quarters · filed 2022-08-09 | $2.44M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $772.00K 10-Q · filed 2022-05-09 | $1.33M derived: sum of 2 quarters · filed 2022-08-09 | $1.64M derived: sum of 3 quarters · filed 2022-08-09 | $1.83M derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $563.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $863.00K derived: sum of 2 quarters · filed 2022-08-09 | $1.06M derived: sum of 3 quarters · filed 2022-08-09 | $1.33M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-09 | $500.00K derived: sum of 2 quarters · filed 2021-11-09 | $764.00K 10-Q · filed 2021-11-09 | $988.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-10 | $509.00K 10-Q · filed 2021-08-10 | $688.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $255.00K 10-Q · filed 2021-05-11 | $488.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $693.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $460.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |